2-methylthio-atp has been researched along with nf 279 in 1 studies
Studies (2-methylthio-atp) | Trials (2-methylthio-atp) | Recent Studies (post-2010) (2-methylthio-atp) | Studies (nf 279) | Trials (nf 279) | Recent Studies (post-2010) (nf 279) |
---|---|---|---|---|---|
265 | 0 | 16 | 13 | 0 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rettinger, J; Schmalzing, G | 1 |
1 other study(ies) available for 2-methylthio-atp and nf 279
Article | Year |
---|---|
Desensitization masks nanomolar potency of ATP for the P2X1 receptor.
Topics: Adenosine Triphosphate; Affinity Labels; Animals; Binding, Competitive; Dose-Response Relationship, Drug; Electrophysiology; Kinetics; Models, Biological; Models, Chemical; Oocytes; Plasmids; Protein Binding; Receptors, Purinergic P2; Receptors, Purinergic P2X; Recombinant Fusion Proteins; Suramin; Thionucleotides; Time Factors; Xenopus | 2004 |